nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—hematopoietic system—hematologic cancer	0.00955	0.218	CbGeAlD
Pamidronate—FDPS—gonad—hematologic cancer	0.00726	0.166	CbGeAlD
Pamidronate—FDPS—blood—hematologic cancer	0.00633	0.144	CbGeAlD
Pamidronate—FDPS—bone marrow—hematologic cancer	0.00613	0.14	CbGeAlD
Pamidronate—FDPS—lung—hematologic cancer	0.00555	0.127	CbGeAlD
Pamidronate—FDPS—testis—hematologic cancer	0.00524	0.119	CbGeAlD
Pamidronate—FDPS—lymph node—hematologic cancer	0.0038	0.0865	CbGeAlD
Pamidronate—Histamine Phosphate—SLC22A1—hematologic cancer	0.00114	1	CrCbGaD
Pamidronate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.6e-05	7.96e-05	CcSEcCtD
Pamidronate—Back pain—Methotrexate—hematologic cancer	7.59e-05	7.95e-05	CcSEcCtD
Pamidronate—Fatigue—Dexamethasone—hematologic cancer	7.59e-05	7.94e-05	CcSEcCtD
Pamidronate—Fatigue—Betamethasone—hematologic cancer	7.59e-05	7.94e-05	CcSEcCtD
Pamidronate—Chills—Epirubicin—hematologic cancer	7.57e-05	7.93e-05	CcSEcCtD
Pamidronate—Pruritus—Etoposide—hematologic cancer	7.57e-05	7.92e-05	CcSEcCtD
Pamidronate—Shock—Prednisone—hematologic cancer	7.54e-05	7.9e-05	CcSEcCtD
Pamidronate—Pain—Dexamethasone—hematologic cancer	7.53e-05	7.88e-05	CcSEcCtD
Pamidronate—Pain—Betamethasone—hematologic cancer	7.53e-05	7.88e-05	CcSEcCtD
Pamidronate—Nervous system disorder—Prednisone—hematologic cancer	7.52e-05	7.87e-05	CcSEcCtD
Pamidronate—Tachycardia—Prednisone—hematologic cancer	7.48e-05	7.83e-05	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—hematologic cancer	7.46e-05	7.81e-05	CcSEcCtD
Pamidronate—Nausea—Gemcitabine—hematologic cancer	7.44e-05	7.79e-05	CcSEcCtD
Pamidronate—Vomiting—Cisplatin—hematologic cancer	7.42e-05	7.77e-05	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisone—hematologic cancer	7.41e-05	7.76e-05	CcSEcCtD
Pamidronate—Rash—Cisplatin—hematologic cancer	7.36e-05	7.71e-05	CcSEcCtD
Pamidronate—Dermatitis—Cisplatin—hematologic cancer	7.35e-05	7.7e-05	CcSEcCtD
Pamidronate—Erythema—Epirubicin—hematologic cancer	7.34e-05	7.69e-05	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—hematologic cancer	7.34e-05	7.69e-05	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—hematologic cancer	7.32e-05	7.66e-05	CcSEcCtD
Pamidronate—Anorexia—Prednisone—hematologic cancer	7.31e-05	7.65e-05	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—hematologic cancer	7.3e-05	7.64e-05	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—hematologic cancer	7.28e-05	7.62e-05	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—hematologic cancer	7.25e-05	7.6e-05	CcSEcCtD
Pamidronate—Feeling abnormal—Dexamethasone—hematologic cancer	7.25e-05	7.59e-05	CcSEcCtD
Pamidronate—Feeling abnormal—Betamethasone—hematologic cancer	7.25e-05	7.59e-05	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—hematologic cancer	7.24e-05	7.59e-05	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—hematologic cancer	7.24e-05	7.59e-05	CcSEcCtD
Pamidronate—Tension—Epirubicin—hematologic cancer	7.21e-05	7.55e-05	CcSEcCtD
Pamidronate—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.2e-05	7.54e-05	CcSEcCtD
Pamidronate—Gastrointestinal pain—Betamethasone—hematologic cancer	7.2e-05	7.54e-05	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—hematologic cancer	7.19e-05	7.53e-05	CcSEcCtD
Pamidronate—Hypersensitivity—Triamcinolone—hematologic cancer	7.15e-05	7.48e-05	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—hematologic cancer	7.13e-05	7.47e-05	CcSEcCtD
Pamidronate—Back pain—Epirubicin—hematologic cancer	7.1e-05	7.44e-05	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—hematologic cancer	7.08e-05	7.42e-05	CcSEcCtD
Pamidronate—Malaise—Methotrexate—hematologic cancer	7.08e-05	7.41e-05	CcSEcCtD
Pamidronate—Dizziness—Etoposide—hematologic cancer	7.07e-05	7.4e-05	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—hematologic cancer	7.06e-05	7.39e-05	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—hematologic cancer	7.05e-05	7.38e-05	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—hematologic cancer	7.04e-05	7.37e-05	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—hematologic cancer	7.02e-05	7.36e-05	CcSEcCtD
Pamidronate—Chills—Doxorubicin—hematologic cancer	7e-05	7.33e-05	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.98e-05	7.31e-05	CcSEcCtD
Pamidronate—Dizziness—Prednisolone—hematologic cancer	6.97e-05	7.3e-05	CcSEcCtD
Pamidronate—Asthenia—Triamcinolone—hematologic cancer	6.96e-05	7.29e-05	CcSEcCtD
Pamidronate—Abdominal pain—Dexamethasone—hematologic cancer	6.96e-05	7.28e-05	CcSEcCtD
Pamidronate—Body temperature increased—Betamethasone—hematologic cancer	6.96e-05	7.28e-05	CcSEcCtD
Pamidronate—Abdominal pain—Betamethasone—hematologic cancer	6.96e-05	7.28e-05	CcSEcCtD
Pamidronate—Body temperature increased—Dexamethasone—hematologic cancer	6.96e-05	7.28e-05	CcSEcCtD
Pamidronate—Nausea—Cisplatin—hematologic cancer	6.93e-05	7.26e-05	CcSEcCtD
Pamidronate—Insomnia—Prednisone—hematologic cancer	6.93e-05	7.26e-05	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—hematologic cancer	6.9e-05	7.22e-05	CcSEcCtD
Pamidronate—Paraesthesia—Prednisone—hematologic cancer	6.88e-05	7.21e-05	CcSEcCtD
Pamidronate—Pruritus—Triamcinolone—hematologic cancer	6.86e-05	7.19e-05	CcSEcCtD
Pamidronate—Cough—Methotrexate—hematologic cancer	6.85e-05	7.17e-05	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—hematologic cancer	6.81e-05	7.14e-05	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—hematologic cancer	6.8e-05	7.12e-05	CcSEcCtD
Pamidronate—Vomiting—Etoposide—hematologic cancer	6.8e-05	7.12e-05	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—hematologic cancer	6.8e-05	7.12e-05	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—hematologic cancer	6.8e-05	7.12e-05	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—hematologic cancer	6.79e-05	7.11e-05	CcSEcCtD
Pamidronate—Agitation—Epirubicin—hematologic cancer	6.75e-05	7.07e-05	CcSEcCtD
Pamidronate—Dyspepsia—Prednisone—hematologic cancer	6.75e-05	7.06e-05	CcSEcCtD
Pamidronate—Rash—Etoposide—hematologic cancer	6.74e-05	7.06e-05	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—hematologic cancer	6.74e-05	7.05e-05	CcSEcCtD
Pamidronate—Headache—Etoposide—hematologic cancer	6.7e-05	7.01e-05	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—hematologic cancer	6.68e-05	7e-05	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—hematologic cancer	6.68e-05	7e-05	CcSEcCtD
Pamidronate—Tension—Doxorubicin—hematologic cancer	6.67e-05	6.98e-05	CcSEcCtD
Pamidronate—Decreased appetite—Prednisone—hematologic cancer	6.66e-05	6.98e-05	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—hematologic cancer	6.65e-05	6.97e-05	CcSEcCtD
Pamidronate—Rash—Prednisolone—hematologic cancer	6.65e-05	6.96e-05	CcSEcCtD
Pamidronate—Dermatitis—Prednisolone—hematologic cancer	6.64e-05	6.96e-05	CcSEcCtD
Pamidronate—Malaise—Epirubicin—hematologic cancer	6.62e-05	6.94e-05	CcSEcCtD
Pamidronate—Fatigue—Prednisone—hematologic cancer	6.61e-05	6.92e-05	CcSEcCtD
Pamidronate—Headache—Prednisolone—hematologic cancer	6.61e-05	6.92e-05	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—hematologic cancer	6.6e-05	6.91e-05	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—hematologic cancer	6.6e-05	6.91e-05	CcSEcCtD
Pamidronate—Syncope—Epirubicin—hematologic cancer	6.59e-05	6.9e-05	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—hematologic cancer	6.57e-05	6.88e-05	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—hematologic cancer	6.57e-05	6.88e-05	CcSEcCtD
Pamidronate—Constipation—Prednisone—hematologic cancer	6.55e-05	6.86e-05	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—hematologic cancer	6.53e-05	6.84e-05	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—hematologic cancer	6.46e-05	6.76e-05	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—hematologic cancer	6.45e-05	6.76e-05	CcSEcCtD
Pamidronate—Dizziness—Triamcinolone—hematologic cancer	6.41e-05	6.72e-05	CcSEcCtD
Pamidronate—Cough—Epirubicin—hematologic cancer	6.41e-05	6.71e-05	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—hematologic cancer	6.4e-05	6.71e-05	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—hematologic cancer	6.36e-05	6.66e-05	CcSEcCtD
Pamidronate—Infection—Methotrexate—hematologic cancer	6.36e-05	6.66e-05	CcSEcCtD
Pamidronate—Nausea—Etoposide—hematologic cancer	6.35e-05	6.65e-05	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—hematologic cancer	6.34e-05	6.64e-05	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisone—hematologic cancer	6.32e-05	6.61e-05	CcSEcCtD
Pamidronate—Asthenia—Betamethasone—hematologic cancer	6.31e-05	6.61e-05	CcSEcCtD
Pamidronate—Asthenia—Dexamethasone—hematologic cancer	6.31e-05	6.61e-05	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—hematologic cancer	6.31e-05	6.6e-05	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—hematologic cancer	6.28e-05	6.58e-05	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—hematologic cancer	6.28e-05	6.58e-05	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—hematologic cancer	6.27e-05	6.57e-05	CcSEcCtD
Pamidronate—Gastrointestinal pain—Prednisone—hematologic cancer	6.27e-05	6.56e-05	CcSEcCtD
Pamidronate—Nausea—Prednisolone—hematologic cancer	6.26e-05	6.56e-05	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—hematologic cancer	6.25e-05	6.55e-05	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—hematologic cancer	6.25e-05	6.55e-05	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—hematologic cancer	6.24e-05	6.54e-05	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—hematologic cancer	6.23e-05	6.52e-05	CcSEcCtD
Pamidronate—Pruritus—Dexamethasone—hematologic cancer	6.23e-05	6.52e-05	CcSEcCtD
Pamidronate—Pruritus—Betamethasone—hematologic cancer	6.23e-05	6.52e-05	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—hematologic cancer	6.19e-05	6.48e-05	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—hematologic cancer	6.18e-05	6.47e-05	CcSEcCtD
Pamidronate—Vomiting—Triamcinolone—hematologic cancer	6.17e-05	6.46e-05	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—hematologic cancer	6.13e-05	6.42e-05	CcSEcCtD
Pamidronate—Rash—Triamcinolone—hematologic cancer	6.12e-05	6.4e-05	CcSEcCtD
Pamidronate—Dermatitis—Triamcinolone—hematologic cancer	6.11e-05	6.4e-05	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—hematologic cancer	6.11e-05	6.39e-05	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—hematologic cancer	6.09e-05	6.38e-05	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—hematologic cancer	6.08e-05	6.37e-05	CcSEcCtD
Pamidronate—Headache—Triamcinolone—hematologic cancer	6.08e-05	6.36e-05	CcSEcCtD
Pamidronate—Body temperature increased—Prednisone—hematologic cancer	6.06e-05	6.34e-05	CcSEcCtD
Pamidronate—Abdominal pain—Prednisone—hematologic cancer	6.06e-05	6.34e-05	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—hematologic cancer	6.04e-05	6.33e-05	CcSEcCtD
Pamidronate—Diarrhoea—Dexamethasone—hematologic cancer	6.02e-05	6.3e-05	CcSEcCtD
Pamidronate—Diarrhoea—Betamethasone—hematologic cancer	6.02e-05	6.3e-05	CcSEcCtD
Pamidronate—Oedema—Epirubicin—hematologic cancer	5.99e-05	6.28e-05	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—hematologic cancer	5.99e-05	6.28e-05	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—hematologic cancer	5.98e-05	6.27e-05	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—hematologic cancer	5.97e-05	6.25e-05	CcSEcCtD
Pamidronate—Infection—Epirubicin—hematologic cancer	5.95e-05	6.24e-05	CcSEcCtD
Pamidronate—Cough—Doxorubicin—hematologic cancer	5.93e-05	6.21e-05	CcSEcCtD
Pamidronate—Shock—Epirubicin—hematologic cancer	5.9e-05	6.17e-05	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—hematologic cancer	5.89e-05	6.17e-05	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—hematologic cancer	5.88e-05	6.16e-05	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—hematologic cancer	5.87e-05	6.15e-05	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—hematologic cancer	5.87e-05	6.14e-05	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—hematologic cancer	5.85e-05	6.13e-05	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.84e-05	6.11e-05	CcSEcCtD
Pamidronate—Dizziness—Betamethasone—hematologic cancer	5.82e-05	6.09e-05	CcSEcCtD
Pamidronate—Dizziness—Dexamethasone—hematologic cancer	5.82e-05	6.09e-05	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—hematologic cancer	5.79e-05	6.07e-05	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—hematologic cancer	5.79e-05	6.07e-05	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—hematologic cancer	5.79e-05	6.06e-05	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—hematologic cancer	5.79e-05	6.06e-05	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—hematologic cancer	5.77e-05	6.04e-05	CcSEcCtD
Pamidronate—Nausea—Triamcinolone—hematologic cancer	5.76e-05	6.03e-05	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—hematologic cancer	5.75e-05	6.02e-05	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—hematologic cancer	5.72e-05	5.99e-05	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—hematologic cancer	5.71e-05	5.98e-05	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—hematologic cancer	5.71e-05	5.98e-05	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—hematologic cancer	5.69e-05	5.96e-05	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisone—hematologic cancer	5.65e-05	5.91e-05	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—hematologic cancer	5.64e-05	5.9e-05	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—hematologic cancer	5.6e-05	5.86e-05	CcSEcCtD
Pamidronate—Vomiting—Dexamethasone—hematologic cancer	5.6e-05	5.86e-05	CcSEcCtD
Pamidronate—Vomiting—Betamethasone—hematologic cancer	5.6e-05	5.86e-05	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—hematologic cancer	5.59e-05	5.86e-05	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—hematologic cancer	5.57e-05	5.83e-05	CcSEcCtD
Pamidronate—Rash—Dexamethasone—hematologic cancer	5.55e-05	5.81e-05	CcSEcCtD
Pamidronate—Rash—Betamethasone—hematologic cancer	5.55e-05	5.81e-05	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—hematologic cancer	5.55e-05	5.81e-05	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—hematologic cancer	5.55e-05	5.81e-05	CcSEcCtD
Pamidronate—Dermatitis—Dexamethasone—hematologic cancer	5.54e-05	5.8e-05	CcSEcCtD
Pamidronate—Dermatitis—Betamethasone—hematologic cancer	5.54e-05	5.8e-05	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.53e-05	5.79e-05	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—hematologic cancer	5.52e-05	5.78e-05	CcSEcCtD
Pamidronate—Headache—Dexamethasone—hematologic cancer	5.51e-05	5.77e-05	CcSEcCtD
Pamidronate—Headache—Betamethasone—hematologic cancer	5.51e-05	5.77e-05	CcSEcCtD
Pamidronate—Infection—Doxorubicin—hematologic cancer	5.51e-05	5.77e-05	CcSEcCtD
Pamidronate—Asthenia—Prednisone—hematologic cancer	5.5e-05	5.76e-05	CcSEcCtD
Pamidronate—Pain—Methotrexate—hematologic cancer	5.48e-05	5.74e-05	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.46e-05	5.72e-05	CcSEcCtD
Pamidronate—Shock—Doxorubicin—hematologic cancer	5.46e-05	5.71e-05	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—hematologic cancer	5.44e-05	5.7e-05	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—hematologic cancer	5.43e-05	5.69e-05	CcSEcCtD
Pamidronate—Pruritus—Prednisone—hematologic cancer	5.42e-05	5.68e-05	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—hematologic cancer	5.42e-05	5.68e-05	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—hematologic cancer	5.41e-05	5.67e-05	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—hematologic cancer	5.38e-05	5.64e-05	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—hematologic cancer	5.36e-05	5.61e-05	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—hematologic cancer	5.34e-05	5.6e-05	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—hematologic cancer	5.33e-05	5.58e-05	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—hematologic cancer	5.29e-05	5.54e-05	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—hematologic cancer	5.28e-05	5.53e-05	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—hematologic cancer	5.28e-05	5.52e-05	CcSEcCtD
Pamidronate—Diarrhoea—Prednisone—hematologic cancer	5.24e-05	5.49e-05	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—hematologic cancer	5.24e-05	5.48e-05	CcSEcCtD
Pamidronate—Nausea—Dexamethasone—hematologic cancer	5.23e-05	5.47e-05	CcSEcCtD
Pamidronate—Nausea—Betamethasone—hematologic cancer	5.23e-05	5.47e-05	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—hematologic cancer	5.21e-05	5.46e-05	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—hematologic cancer	5.18e-05	5.43e-05	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.17e-05	5.42e-05	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—hematologic cancer	5.17e-05	5.41e-05	CcSEcCtD
Pamidronate—Constipation—Epirubicin—hematologic cancer	5.13e-05	5.37e-05	CcSEcCtD
Pamidronate—Pain—Epirubicin—hematologic cancer	5.13e-05	5.37e-05	CcSEcCtD
Pamidronate—Dizziness—Prednisone—hematologic cancer	5.07e-05	5.31e-05	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—hematologic cancer	5.06e-05	5.3e-05	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—hematologic cancer	5.06e-05	5.3e-05	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.05e-05	5.29e-05	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—hematologic cancer	5.02e-05	5.25e-05	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—hematologic cancer	4.98e-05	5.21e-05	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—hematologic cancer	4.94e-05	5.18e-05	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—hematologic cancer	4.94e-05	5.17e-05	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—hematologic cancer	4.93e-05	5.16e-05	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—hematologic cancer	4.9e-05	5.13e-05	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—hematologic cancer	4.88e-05	5.11e-05	CcSEcCtD
Pamidronate—Vomiting—Prednisone—hematologic cancer	4.87e-05	5.1e-05	CcSEcCtD
Pamidronate—Rash—Prednisone—hematologic cancer	4.83e-05	5.06e-05	CcSEcCtD
Pamidronate—Dermatitis—Prednisone—hematologic cancer	4.83e-05	5.06e-05	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—hematologic cancer	4.82e-05	5.05e-05	CcSEcCtD
Pamidronate—Headache—Prednisone—hematologic cancer	4.8e-05	5.03e-05	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.79e-05	5.01e-05	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—hematologic cancer	4.78e-05	5.01e-05	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—hematologic cancer	4.74e-05	4.97e-05	CcSEcCtD
Pamidronate—Pain—Doxorubicin—hematologic cancer	4.74e-05	4.97e-05	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—hematologic cancer	4.74e-05	4.96e-05	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—hematologic cancer	4.74e-05	4.96e-05	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—hematologic cancer	4.72e-05	4.94e-05	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—hematologic cancer	4.6e-05	4.81e-05	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—hematologic cancer	4.57e-05	4.79e-05	CcSEcCtD
Pamidronate—Nausea—Prednisone—hematologic cancer	4.55e-05	4.77e-05	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.54e-05	4.75e-05	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—hematologic cancer	4.53e-05	4.74e-05	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—hematologic cancer	4.42e-05	4.62e-05	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—hematologic cancer	4.38e-05	4.59e-05	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—hematologic cancer	4.38e-05	4.59e-05	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—hematologic cancer	4.38e-05	4.59e-05	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—hematologic cancer	4.3e-05	4.5e-05	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—hematologic cancer	4.24e-05	4.44e-05	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—hematologic cancer	4.24e-05	4.43e-05	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—hematologic cancer	4.1e-05	4.29e-05	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—hematologic cancer	4.09e-05	4.28e-05	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—hematologic cancer	4.07e-05	4.26e-05	CcSEcCtD
Pamidronate—Rash—Methotrexate—hematologic cancer	4.04e-05	4.23e-05	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—hematologic cancer	4.03e-05	4.22e-05	CcSEcCtD
Pamidronate—Headache—Methotrexate—hematologic cancer	4.01e-05	4.2e-05	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—hematologic cancer	3.98e-05	4.17e-05	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—hematologic cancer	3.96e-05	4.15e-05	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—hematologic cancer	3.92e-05	4.11e-05	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—hematologic cancer	3.81e-05	3.99e-05	CcSEcCtD
Pamidronate—Nausea—Methotrexate—hematologic cancer	3.8e-05	3.98e-05	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—hematologic cancer	3.79e-05	3.97e-05	CcSEcCtD
Pamidronate—Rash—Epirubicin—hematologic cancer	3.78e-05	3.96e-05	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—hematologic cancer	3.78e-05	3.95e-05	CcSEcCtD
Pamidronate—Headache—Epirubicin—hematologic cancer	3.75e-05	3.93e-05	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—hematologic cancer	3.67e-05	3.84e-05	CcSEcCtD
Pamidronate—Nausea—Epirubicin—hematologic cancer	3.56e-05	3.73e-05	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—hematologic cancer	3.53e-05	3.69e-05	CcSEcCtD
Pamidronate—Rash—Doxorubicin—hematologic cancer	3.5e-05	3.66e-05	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—hematologic cancer	3.49e-05	3.66e-05	CcSEcCtD
Pamidronate—Headache—Doxorubicin—hematologic cancer	3.47e-05	3.64e-05	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—hematologic cancer	3.29e-05	3.45e-05	CcSEcCtD
